According to a study presented at the 53rd Annual Meeting of the American Society for Radiation Oncology, prostate cancer (PCa) patients who use the antioxidant supplement beta-carotene during radiation therapy do not appear to have an increased risk of dying from the disease 10 years after treatment.
More about:
This Site and third parties who place advertisements on this Site may collect and use information about your visits to this Site and other websites in order to provide advertisements about goods and services of interest to you. If you would like to obtain more information about these advertising practices and to make choices about online behavioral advertising, please click here
